To the best of our knowledge, this study is the first to report the potential pathogenic role of CXCL12/SDF-1 in PCOS and incremental serum levels of CXCL12/SDF-1 in overweight patients with PCOS. This evidence concerns the gene CXCL12 and polycystic ovary syndrome.